2017
DOI: 10.1134/s0012496617010094
|View full text |Cite
|
Sign up to set email alerts
|

Lymphocytes incubated in the presence of IL-2 lose the capacity for chemotaxis but acquire antitumor activity

Abstract: Naïve non-activated lymphocytes are capable of releasing the chemoattractant complex Tag7-Mts1 and can migrate along the gradient of its concentration. After activation of these cells by IL-2, they acquire the abilities to kill tumor cells and to release the cytotoxic Tag7-Hsp70 complex, which is accompanied by a loss of both the Tag7-Mts1-mediated lymphocyte chemotaxis and the ability to release this chemoattractant into the conditioned medium.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…In particular, it stimulates the proliferation of naive CD8 lymphocytes and their maturation into cytotoxic lymphocytes capable of secreting IFNγ and killing infected cells [14]. Long-term incubation of lymphocytes with IL-2 induces their differentiation into LAK cells cytotoxic against tumor cells [14,15].…”
Section: Introductionmentioning
confidence: 99%
“…In particular, it stimulates the proliferation of naive CD8 lymphocytes and their maturation into cytotoxic lymphocytes capable of secreting IFNγ and killing infected cells [14]. Long-term incubation of lymphocytes with IL-2 induces their differentiation into LAK cells cytotoxic against tumor cells [14,15].…”
Section: Introductionmentioning
confidence: 99%
“…It is noteworthy that in vitro proliferation of antigen specific T-cells derived from cattle with prior immunisation with a BEFV-derived immunogen was associated with increased IL-2 production (Uren et al, 1993). Interleukin-2 is an important growth factor for T-cells, NK cells, and B-cells and promotes the activation of lymphokineactivated killer cells (Arai et al, 1992;Jounaidi et al, 2011;Romanova et al, 2017).…”
Section: Discussionmentioning
confidence: 99%